Share Twitter LinkedIn Facebook Email John Leppert, M.D., M.S. Associate Professor – Med Center Line, Urology At Stanford University Discusses Which Patient For Which Treatment. At the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018. Advertisement
Alcohol Consumption and Cancer Risk: Insights from the 2025 Surgeon General’s Advisory Breast Cancer 3 Mins Read
Genitourinary Cancer [2025] Treatment Breakthroughs: ASCO GU 2025 Highlights Nataliya Mar, MD – MOASC Genitourinary 6 Mins Read